Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.
Read More…
Industry, Sector and Symbol
Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
Phone732-873-5133
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$50.55 million
Profitability
Miscellaneous
Employees2,400
Next Earnings Date3/18/2020 (Estimated)
OptionableNot Optionable
Medical Transcription Billing (NASDAQ:MTBC) Frequently Asked Questions
What is Medical Transcription Billing's stock symbol?
Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."
How were Medical Transcription Billing's earnings last quarter?
Medical Transcription Billing Corp (NASDAQ:MTBC) issued its earnings results on Wednesday, November, 6th. The technology company reported ($0.14) earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.14). The technology company earned $16.85 million during the quarter, compared to analysts' expectations of $16.06 million. Medical Transcription Billing had a negative return on equity of 8.85% and a negative net margin of 5.01%. View Medical Transcription Billing's Earnings History.
When is Medical Transcription Billing's next earnings date?
What guidance has Medical Transcription Billing issued on next quarter's earnings?
Medical Transcription Billing updated its FY 2019 earnings guidance on Tuesday, October, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $62.677 million, compared to the consensus revenue estimate of $64.4 million.
What price target have analysts set for MTBC?
3 brokerages have issued twelve-month target prices for Medical Transcription Billing's shares. Their forecasts range from $6.00 to $6.00. On average, they anticipate Medical Transcription Billing's share price to reach $6.00 in the next year. This suggests a possible upside of 57.9% from the stock's current price. View Analyst Price Targets for Medical Transcription Billing.
What is the consensus analysts' recommendation for Medical Transcription Billing?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing.
Has Medical Transcription Billing been receiving favorable news coverage?
Headlines about MTBC stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medical Transcription Billing earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Medical Transcription Billing.
Are investors shorting Medical Transcription Billing?
Medical Transcription Billing saw a decline in short interest in the month of October. As of October 31st, there was short interest totalling 42,000 shares, a decline of 64.7% from the September 30th total of 119,000 shares. Based on an average daily volume of 29,800 shares, the short-interest ratio is currently 1.4 days. Currently, 0.7% of the company's shares are short sold. View Medical Transcription Billing's Current Options Chain.
Who are some of Medical Transcription Billing's key competitors?
Some companies that are related to Medical Transcription Billing include Inspired Entertainment (INSE), MAM Software Group (MAMS), SharpSpring (SHSP), Cyren (CYRN), Great Elm Capital Group (GEC), Gridsum (GSUM), NetSol Technologies (NTWK), Aware (AWRE), FalconStor Software (FALCD), CLPS (CLPS), Mobivity (MFON), ImageWare Systems (IWSY), Astea International (ATEA), Where Food Comes From (WFCF) and FORESIGHT AUTON/S (FRSX).
What other stocks do shareholders of Medical Transcription Billing own?
How do I buy shares of Medical Transcription Billing?
Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Medical Transcription Billing's stock price today?
One share of MTBC stock can currently be purchased for approximately $3.80.
How big of a company is Medical Transcription Billing?
Medical Transcription Billing has a market capitalization of $46.44 million and generates $50.55 million in revenue each year. The technology company earns $-2,140,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Medical Transcription Billing employs 2,400 workers across the globe.View Additional Information About Medical Transcription Billing.
What is Medical Transcription Billing's official website?
How can I contact Medical Transcription Billing?
Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.
MarketBeat Community Rating for Medical Transcription Billing (NASDAQ MTBC)
MarketBeat's community ratings are surveys of what our community members think about Medical Transcription Billing and other stocks. Vote "Outperform" if you believe MTBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
